Istamex (Chlorphenamine Maleate)

Chlorphenamine maleate is used to relieve symptoms caused by histamine release in allergic conditions.

• Allergic rhinitis: reduces sneezing, nasal itching and runny nose.
• Urticaria (hives): alleviates itching and skin wheals.
• Allergic conjunctivitis: eases eye itching, redness and tearing.

• Chlorphenamine maleate acts as a competitive antagonist at histamine H1 receptors, preventing histamine from binding and activating these receptors on mast cells, smooth muscle, and vascular endothelium. This blockade reduces the vascular permeability, nerve stimulation and smooth‑muscle contraction that underlie typical allergic manifestations, thereby providing symptomatic relief.

Chlorphenamine maleate may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dry mouth: reduced salivation leading to a parched sensation.
• Blurred vision: temporary difficulty focusing.
• Constipation: slowed intestinal motility.
• Headache: mild to moderate cranial pain.
• Nausea: feeling of stomach upset.

Serious or Rare Side Effects

• Tachycardia: rapid heart rate requiring medical attention.
• Anaphylaxis: severe allergic reaction with breathing difficulty.
• Seizures: convulsive episodes in susceptible individuals.
• Blood dyscrasias: abnormal blood cell counts.
• Hepatic dysfunction: signs of liver injury.
• Cardiac arrhythmias: irregular heart rhythms.

When using Chlorphenamine maleate, consider the following safety measures.

• Pediatric use: follow prescriber guidance for children’s dosing.
• Driving and machinery: avoid operating vehicles if drowsiness occurs.
• Alcohol consumption: limit intake as it may enhance sedation.
• Glaucoma: use with caution in patients with narrow‑angle glaucoma.
• Urinary retention: monitor individuals with prostate enlargement.
• Store at room temperature: keep in the original packaging, protect from moisture and heat.

Chlorphenamine maleate can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Other central nervous system depressants: additive sedation.
• Anticholinergic agents: increased dry‑mouth and constipation.

Moderate Interactions (Monitor Closely)

• CYP2D6 substrates (e.g., metoprolol): possible altered plasma levels.
• Additional antihistamines: heightened anticholinergic effects.
• Sedative antidepressants: enhanced drowsiness.
• Antihypertensives: potential additive blood‑pressure lowering.
• Antipsychotics: increased risk of extrapyramidal symptoms.